<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><title>SEC FORM 
            3</title><style type="text/css">
              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; 
              		font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}
              body {background: white;}
      </style></head><body>SEC Form 3 
   <table width="100%" border="0" cellspacing="0" cellpadding="4"><tr><td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 3</td><td rowspan="1" width="60%" valign="middle" align="center"><span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span></td><td rowspan="1" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box"><tr><td class="FormTextC">OMB APPROVAL</td></tr><tr><td><table width="100%" border="0" summary="OMB Interior Box"><tr><td class="SmallFormText" colspan="3">OMB Number:</td><td class="SmallFormTextR">3235-0104</td></tr><tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr><tr><td class="SmallFormText" colspan="3">hours per response:</td><td class="SmallFormTextR">0.5</td></tr></table></td></tr></table></td></tr></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><tr><td rowspan="3" width="30%" valign="top"><span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0002143915">Mohammed Faiz</a></td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" class="MedSmallFormText">(Last)</td><td width="33%" class="MedSmallFormText">(First)</td><td width="33%" class="MedSmallFormText">(Middle)</td></tr></table><table border="0" width="100%"><tr><td><span class="FormData">C/O CERTARA, INC.</span></td></tr><tr><td><span class="FormData">4 RADNOR CORPORATE CENTER, SUITE 350</span></td></tr></table><hr width="98%"><span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr><td width="33%"><span class="FormData">RADNOR</span></td><td width="33%"><span class="FormData">
				PENNSYLVANIA
			</span></td><td width="33%"><span class="FormData">19087</span></td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" class="MedSmallFormText">(City)</td><td width="33%" class="MedSmallFormText">(State)</td><td width="33%" class="MedSmallFormText">(Zip)</td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" colspen="3"><span class="FormData">UNITED STATES</span></td></tr></table><hr width="98%"><span class="MedSmallFormText">(Country)</span></td><td rowspan="3" width="15%" valign="top"><span class="MedSmallFormText">2. Date of Event Requiring Statement
         (Month/Day/Year)</span><br><span class="FormData">07/15/2026</span></td><td valign="top" colspan="2"><span class="MedSmallFormText">3. Issuer Name <b>and</b> Ticker or Trading Symbol
      </span><br><a href="/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001827090">Certara, Inc.</a>
     [ <span class="FormData">CERT</span> ]
   </td></tr><tr><td rowspan="1" width="30%" valign="top"><span class="MedSmallFormText">3a. Foreign Trading Symbol
		 <br></span></td><td valign="top"><span class="MedSmallFormText">5. If Amendment, Date of Original Filed
         (Month/Day/Year)</span><br></td></tr><tr><td rowspan="1" width="30%" valign="top"><span class="MedSmallFormText">4. Relationship of Reporting Person(s) to Issuer
      </span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%"><tr><td width="15%" align="center"></td><td width="35%" class="MedSmallFormText">Director</td><td width="15%" align="center"></td><td width="35%" class="MedSmallFormText">10% Owner</td></tr><tr><td align="center"><span class="FormData">X</span></td><td class="MedSmallFormText">Officer (give title below)</td><td align="center"></td><td class="MedSmallFormText">Other (specify below)</td></tr><tr><td width="15%" align="center"></td><td width="35%" align="left" style="color: blue">Interim CFO</td><td width="15%" align="center"></td><td width="35%" align="left" style="color: blue"></td></tr></table></td><td valign="top"><span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
      </span><table border="0" width="100%"><tr><td width="15%" align="center"><span class="FormData">X</span></td><td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td></tr><tr><td width="15%" align="center"></td><td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td></tr></table></td></tr></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><thead><tr><th width="100%" valign="top" colspan="4" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Beneficially Owned</b></th></tr><tr><th width="44%" valign="top" align="left" class="MedSmallFormText">1. Title of Security (Instr. 
      4)
   </th><th width="19%" valign="top" align="left" class="MedSmallFormText">2. 
      Amount of Securities Beneficially Owned (Instr. 
      4)
   </th><th width="11%" valign="top" align="left" class="MedSmallFormText">3. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th><th width="26%" valign="top" align="left" class="MedSmallFormText">4. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th></tr></thead><tbody><tr><td align="left"><span class="FormData">Common Stock</span></td><td align="center"><span class="FormData">163,686</span></td><td align="center"><span class="FormData">D</span></td><td align="left"><span class="FormData"></span></td></tr></tbody></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><thead><tr><th width="100%" valign="top" colspan="8" align="center" class="FormTextC"><b>Table II - Derivative Securities Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b></th></tr><tr><th width="35%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Derivative Security (Instr. 
      4)
   </th><th width="9%" valign="top" colspan="2" align="left" class="MedSmallFormText">2. Date Exercisable and Expiration Date 
      (Month/Day/Year)</th><th width="26%" valign="top" colspan="2" align="left" class="MedSmallFormText">3. Title and Amount of Securities Underlying Derivative Security (Instr. 
      4)
   </th><th width="7%" valign="top" rowspan="2" align="left" class="MedSmallFormText">4. Conversion or Exercise Price of Derivative Security
   </th><th width="8%" valign="top" rowspan="2" align="left" class="MedSmallFormText">5. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th><th width="15%" valign="top" rowspan="2" align="left" class="MedSmallFormText">6. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th></tr><tr><th width="4%" valign="bottom" align="center" class="MedSmallFormText">Date Exercisable</th><th width="5%" valign="bottom" align="center" class="MedSmallFormText">Expiration Date</th><th width="20%" valign="bottom" align="center" class="MedSmallFormText">Title</th><th width="6%" valign="bottom" align="center" class="MedSmallFormText">Amount or Number of Shares</th></tr></thead><tbody><tr><td align="left"><span class="FormData">Restricted Stock Units</span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(1)</sup></span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(1)</sup></span></td><td align="center"><span class="FormData">Common Stock</span></td><td align="center"><span class="FormData">6,330</span></td><td align="center"><span class="FormText">$</span><span class="FormData">0</span></td><td align="center"><span class="FormData">D</span></td><td align="left"><span class="FormData"></span></td></tr><tr><td align="left"><span class="FormData">Restricted Stock Units</span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(2)</sup></span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(2)</sup></span></td><td align="center"><span class="FormData">Common Stock</span></td><td align="center"><span class="FormData">13,290</span></td><td align="center"><span class="FormText">$</span><span class="FormData">0</span></td><td align="center"><span class="FormData">D</span></td><td align="left"><span class="FormData"></span></td></tr><tr><td align="left"><span class="FormData">Performance  Stock Units</span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(3)</sup></span></td><td align="center"><span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(3)</sup></span></td><td align="center"><span class="FormData">Common Stock</span></td><td align="center"><span class="FormData">8,544</span></td><td align="center"><span class="FormText">$</span><span class="FormData">0</span></td><td align="center"><span class="FormData">D</span></td><td align="left"><span class="FormData"></span></td></tr></tbody></table><table border="0" width="100%"><tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr><tr><td class="FootnoteData">1. Each restricted stock unit ("RSU") was granted on April 1, 2024, pursuant to the Certara, Inc. ("Certara") 2020 Incentive Plan ("2020 Incentive Plan"). Each RSU represents a right to receive one share of Certara common stock or the cash equivalent thereof. One-third of the RSUs vested and settled on April 1, 2025, and one-third vested and settled on April 1, 2026. The remaining one-third of the RSUs will vest and settle on April 1, 2027, subject to the reporting person's continued service through the applicable vesting date.</td></tr><tr><td class="FootnoteData">2. Each RSU was granted on July 11, 2025, pursuant to the 2020 Incentive Plan. Each RSU represents a right to receive one share of Certara common stock or the cash equivalent thereof. One-third of the RSUs vested and settled on April 1, 2026. The remaining two-thirds of the RSUs will vest and settle in two equal installments on April 1, 2027 and April 1, 2028, subject to the reporting person's continued service through each applicable vesting date</td></tr><tr><td class="FootnoteData">3. Each performance stock unit ("PSU") was granted on July 11, 2025, pursuant to the terms of Certara's 2025 Long-Term Incentive Plan for Executives, as approved by the Compensation Committee of Certara's Board of Directors under the 2020 Incentive Plan. Each PSU represents a right to receive one share of Certara common stock. The reporting person will be entitled to receive between 0% and 200% of the target number of PSUs based on Certara's performance against certain total shareholder return thresholds during the performance period ending March 31, 2028.</td></tr></table><table width="100%" border="0"><tr><td width="60%"></td><td width="20%"><u><span class="FormData">/s/ Daniel D. Corcoran, as Attorney-in-Fact for Faiz Mohammed</span></u></td><td width="20%"><u><span class="FormData">07/17/2026</span></u></td></tr><tr><td></td><td class="MedSmallFormText">** Signature of Reporting Person</td><td class="MedSmallFormText">Date</td></tr><tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr><tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person, 
                  <i>see</i>

                  Instruction 
                  5

                  (b)(v).</td></tr><tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations 
                  <i>See</i>

                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr><tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, 
                  <i>see</i>

                  Instruction 6 for procedure.</td></tr><tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr><tr><td colspan="3" class="MedSmallFormText"><b>* Form 3: SEC 1473 (03-26)</b></td></tr></table></body></html>
